Intraoperative radiotherapy in the multimodality approach to colorectal cancer

Dieter Hahnloser, Michael Haddock, Heidi Nelson

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The addition of intraoperative radiotherapy (IORT) to the multimodality approach for the treatment of locally advanced and locally recurrent colorectal cancer seems to result in improvements in local control and long-term survival. Local control and survival are most likely in patients in whom a gross total resection is accomplished. Peripheral nerve is the dose-limiting structure for patients treated with IORT. Further improvements in local control require the addition of dose modifiers during external beam radiotherapy or IORT. Distant relapse remains problematic, and effective systemic therapy is necessary to significantly improve long-term survival.

Original languageEnglish (US)
Pages (from-to)993-1013
Number of pages21
JournalSurgical Oncology Clinics of North America
Volume12
Issue number4
DOIs
StatePublished - Oct 2003

Fingerprint

Colorectal Neoplasms
Radiotherapy
Survival
Peripheral Nerves
Recurrence
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Intraoperative radiotherapy in the multimodality approach to colorectal cancer. / Hahnloser, Dieter; Haddock, Michael; Nelson, Heidi.

In: Surgical Oncology Clinics of North America, Vol. 12, No. 4, 10.2003, p. 993-1013.

Research output: Contribution to journalArticle

@article{30a16911ff974e479ec11c76ca4f0734,
title = "Intraoperative radiotherapy in the multimodality approach to colorectal cancer",
abstract = "The addition of intraoperative radiotherapy (IORT) to the multimodality approach for the treatment of locally advanced and locally recurrent colorectal cancer seems to result in improvements in local control and long-term survival. Local control and survival are most likely in patients in whom a gross total resection is accomplished. Peripheral nerve is the dose-limiting structure for patients treated with IORT. Further improvements in local control require the addition of dose modifiers during external beam radiotherapy or IORT. Distant relapse remains problematic, and effective systemic therapy is necessary to significantly improve long-term survival.",
author = "Dieter Hahnloser and Michael Haddock and Heidi Nelson",
year = "2003",
month = "10",
doi = "10.1016/S1055-3207(03)00091-7",
language = "English (US)",
volume = "12",
pages = "993--1013",
journal = "Surgical Oncology Clinics of North America",
issn = "1055-3207",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Intraoperative radiotherapy in the multimodality approach to colorectal cancer

AU - Hahnloser, Dieter

AU - Haddock, Michael

AU - Nelson, Heidi

PY - 2003/10

Y1 - 2003/10

N2 - The addition of intraoperative radiotherapy (IORT) to the multimodality approach for the treatment of locally advanced and locally recurrent colorectal cancer seems to result in improvements in local control and long-term survival. Local control and survival are most likely in patients in whom a gross total resection is accomplished. Peripheral nerve is the dose-limiting structure for patients treated with IORT. Further improvements in local control require the addition of dose modifiers during external beam radiotherapy or IORT. Distant relapse remains problematic, and effective systemic therapy is necessary to significantly improve long-term survival.

AB - The addition of intraoperative radiotherapy (IORT) to the multimodality approach for the treatment of locally advanced and locally recurrent colorectal cancer seems to result in improvements in local control and long-term survival. Local control and survival are most likely in patients in whom a gross total resection is accomplished. Peripheral nerve is the dose-limiting structure for patients treated with IORT. Further improvements in local control require the addition of dose modifiers during external beam radiotherapy or IORT. Distant relapse remains problematic, and effective systemic therapy is necessary to significantly improve long-term survival.

UR - http://www.scopus.com/inward/record.url?scp=0345449057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345449057&partnerID=8YFLogxK

U2 - 10.1016/S1055-3207(03)00091-7

DO - 10.1016/S1055-3207(03)00091-7

M3 - Article

C2 - 14989129

AN - SCOPUS:0345449057

VL - 12

SP - 993

EP - 1013

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

SN - 1055-3207

IS - 4

ER -